Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Medical Research

HINJ, PhRMA, Others Challenge NJ Attorney General’s Push to Limit Compensation to Prescribing Doctors

Dean J. Paranicas, President and Chief Executive Officer, HINJ

Trenton, NJ, October 23, 2017 — WHYY Public Radio Philadelphia’s Joe Hernandez reports that, in a new push to fight the opioid crisis, New Jersey officials are trying to stop the flow of legal but highly addictive painkillers at the source: doctors.

A proposed rule change by N.J. Attorney General Christopher Porrino would restrict the amount of money and other compensation drug companies can give out to doctors and other prescribers.  In doing so, state officials hope medical professionals will feel less pressure to prescribe opioids created and sold by the same companies that ply them with gifts and food.

But at a Thursday public hearing in Newark, representatives of the state’s pharmaceutical and medical industries criticized the potential rule change, questioning why it would apply to all drugs and claiming it would damage patient care and drive providers out of state. Continue reading

Stockton University Brain Research Team Seeking Volunteers in Atlantic City Area

Galloway, NJ, August 18, 2017 — Stockton University is seeking volunteers for a research project being conducted in Atlantic City, which will explore which lifestyle factors have the most significant impact on the degree of connectivity among different regions of the brain.

“As we age, we routinely participate in screenings of blood pressure, cholesterol and blood sugar,” noted Jessica Fleck, associate professor of Psychology.  “However, many individuals have never participated in a screening of brain health and function.” Continue reading

Congress Boosts Research Funding in Cancer, Alzheimer’s, Precision Medicine, BRAIN Initiative and ‘Superbugs’

Washington, DC, May 2, 2017 — Ariana Eunjung Cha reports in The Washington Post that Congress unveiled a bipartisan budget late Sunday that contains a number of welcome surprises for researchers who had been panicking since March, when President Trump proposed deep funding cuts for science and health.

Under the deal, the National Institutes of Health will get a $2 billion boost in fiscal year 2017, as it did the previous year.

Trump had proposed cutting the NIH budget by about one-fifth, or $6 billion, in a draft 2018 budget.

Here are some of the big research winners: Continue reading

Medical Research, Science Funding Spared Under Budget Deal — But More Battles Ahead

Washington, DC, May 2, 2017 —Joel Achenbach, Ben Guarino, Sarah Kaplan and Darryl Fears report in The Washington Post that the lights will stay on in the federal government, and also in the countless laboratories and universities that depend on federal funding for scientific and medical research.

That’s one upshot of the bipartisan budget deal congressional negotiators reached late Sunday.

The bill, clocking in at more than 1,600 pages, is likely to pass both houses of Congress and be signed into law by President Trump this week.  It covers funding through September. Continue reading